Welcome to LookChem.com Sign In|Join Free

CAS

  • or

152857-79-9

Post Buying Request

152857-79-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

152857-79-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 152857-79-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,2,8,5 and 7 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 152857-79:
(8*1)+(7*5)+(6*2)+(5*8)+(4*5)+(3*7)+(2*7)+(1*9)=159
159 % 10 = 9
So 152857-79-9 is a valid CAS Registry Number.

152857-79-9Downstream Products

152857-79-9Relevant articles and documents

Discovery of a Novel Series of Potent and Selective Alkynylthiazole-Derived PI3KγInhibitors

Bandarage, Upul K.,Aronov, Alex M.,Cao, Jingrong,Come, Jon H.,Cottrell, Kevin M.,Davies, Robert J.,Giroux, Simon,Jacobs, Marc,Mahajan, Sudipta,Messersmith, David,Moody, Cameron S.,Swett, Rebecca,Xu, Jinwang

, p. 129 - 135 (2021)

Phosphoinositide 3-kinases (PI3Ks) are a family of enzymes that control a wide variety of cellular functions such as cell growth, proliferation, differentiation, motility, survival, and intracellular trafficking. PI3Kγplays a critical role in mediating leukocyte chemotaxis as well as mast cell degranulation, making it a potentially interesting target for autoimmune and inflammatory diseases. We previously disclosed a novel series of PI3Kγinhibitors derived from a benzothiazole core. The truncation of the benzothiazole core led to the discovery of a structurally diverse alkynyl thiazole series which displayed high PI3Kγpotency and subtype selectivity. Further medicinal chemistry optimization of the alkynyl thiazole series led to identification of compounds such as 14 and 32, highly potent, subtype selective, and CNS penetrant PI3Kγinhibitors. Compound 14 showed robust inhibition of PI3Kγmediated neutrophil migration in vivo.

SYNTHESIS OF THERAPEUTIC AND DIAGNOSTIC DRUGS CENTERED ON REGIOSELECTIVE AND STEREOSELECTIVE RING OPENING OF AZIRIDINIUM IONS

-

Paragraph 0114, (2013/12/03)

Stereoselective and regioselective synthesis of compounds via nucleophilic ring opening reactions of aziridinium ions for use in stereoselective and regioselective synthesis of therapeutic and diagnostic compounds.

Stereoselective deprotonation of chiral and achiral 2-aminoalkyl carbamates: Synthesis of optically active β-amino alcohols via 1-oxy- substituted alkyllithium intermediates

Schwerdtfeger, J?rg,Kolczewski, Sabine,Weber, Berthold,Fr?hlich, Roland,Hoppe, Dieter

, p. 1573 - 1592 (2007/10/03)

A facile protocol for the electrophilic C-substitution (methylation, acylation, α-hydroxyalkylation, and carboxylation) of several 2-(N,N- dibenzylamino)alkan-1-ols via the carbamates 10 is reported. The stereochemistry of the lithiation is greatly influenced by the complexing diamine. The substrate-directed selection between the diastereotopic a-pro-R and pro-S protons in the TMEDA-assisted deprotonation is largely shifted towards pro-S-selectivity in the presence of (-)-sparteine (4). Each of both diastereomeric series is readily accessible in several cases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 152857-79-9